Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel N Blankson

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
Current Opinion in HIV and AIDS|April 18, 2009
Viral reservoirs and HIV-specific immunityJoel N Blankson
Current Opinion in HIV and AIDS|March 15, 2011
The study of elite controllers: a pure academic exercise or a potential pathway to an HIV-1 vaccine?Joel N Blankson
Antiviral Research|September 8, 2009
Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?Joel N Blankson
Discovery Medicine|March 31, 2010
Control of HIV-1 replication in elite suppressorsJoel N Blankson
The Journal of Infectious Diseases|April 5, 2023
Bivalent COVID-19 Vaccines: Can the Original Antigenic Sin Be Forgiven?Joel N Blankson
Annals of Internal Medicine|November 16, 2021
The Esperanza Patient: More Hope for a Sterilizing HIV-1 CureJoel N Blankson
Nature Immunology|August 23, 2024
Long-term antiretroviral therapy rejuvenates the HIV-specific CD8<sup>+</sup> T cell responseJoel N Blankson
Nature Medicine|August 6, 2011
Killing the messenger to maintain control of HIVJoel N Blankson
The AIDS Reader|May 20, 2005
Primary HIV-1 infection: to treat or not to treat?Joel N Blankson
Current Opinion in HIV and AIDS|March 6, 2026
What can spontaneous controllers, posttreatment controllers and postintervention controllers teach us about an HIV cure?Joel N Blankson
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Current Opinion in HIV and AIDS|April 18, 2009
Viral reservoirs and HIV-specific immunityJoel N Blankson
Current Opinion in HIV and AIDS|March 15, 2011
The study of elite controllers: a pure academic exercise or a potential pathway to an HIV-1 vaccine?Joel N Blankson
Antiviral Research|September 8, 2009
Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?Joel N Blankson
Discovery Medicine|March 31, 2010
Control of HIV-1 replication in elite suppressorsJoel N Blankson
The Journal of Infectious Diseases|April 5, 2023
Bivalent COVID-19 Vaccines: Can the Original Antigenic Sin Be Forgiven?Joel N Blankson
Annals of Internal Medicine|November 16, 2021
The Esperanza Patient: More Hope for a Sterilizing HIV-1 CureJoel N Blankson
Nature Immunology|August 23, 2024
Long-term antiretroviral therapy rejuvenates the HIV-specific CD8<sup>+</sup> T cell responseJoel N Blankson
Nature Medicine|August 6, 2011
Killing the messenger to maintain control of HIVJoel N Blankson
The AIDS Reader|May 20, 2005
Primary HIV-1 infection: to treat or not to treat?Joel N Blankson
Current Opinion in HIV and AIDS|March 6, 2026
What can spontaneous controllers, posttreatment controllers and postintervention controllers teach us about an HIV cure?Joel N Blankson
Pageof 16